A Review of Methotrexate‐Induced Accelerated Nodulosis
Identifieur interne : 002246 ( Main/Exploration ); précédent : 002245; suivant : 002247A Review of Methotrexate‐Induced Accelerated Nodulosis
Auteurs : Edna Patatanian [États-Unis] ; Dennis F. Thompson [États-Unis]Source :
- Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy [ 0277-0008 ] ; 2002-09.
English descriptors
- Teeft :
- Adenosine, Antiinflammatory effects, Arthritis, Arthritis rheum, Case reports, Causality, Colchicine, Colchicine regression, Concurrent vasculitis, High percentage, Hydroxychloroquine, Methotrexate, Methotrexate therapy, Naranjo scale, Nodule, Nodulosis, Pharmacotherapy volume, Receptor, Rheum, Rheumatoid, Rheumatoid arthritis, Rheumatoid factor, Rheumatoid nodules, Rheumatol, Vasculitis.
Abstract
Objective. To review the English‐language literature on methotrexate‐induced accelerated nodulosis, compile case reports of its occurrences, and make recommendations on the clinical management of patients. Methods. A comprehensive search of MEDLINE, TOXLINE, and EMBASE databases was performed, along with a bibliographic search of key articles. Case reports were compiled separately. The Naranjo adverse drug reaction probability scale was used to assess causality. Results. Twenty‐seven case reports of patients with methotrexate‐induced accelerated nodulosis were identified along with one series of 10 patients and one series of 21 patients. Probability assessment for most of the case reports was weak and left room for doubt regarding causality. Most patients were older than 50 years, were positive for rheumatoid factor, and had nodules on their fingers but did not have concurrent vasculitis. Some unusual sites of nodulosis were the larynx, lungs, Achilles tendon, and heart. Of 19 patients given hydroxychloroquine, colchicine, sulfasalazine, azathioprine, or D‐penicillamine, all except two showed regression of the nodules; the response was unknown for one patient. Conclusion. Controversy surrounds the management of patients who develop accelerated nodulosis while receiving methotrexate therapy for rheumatoid arthritis. Our review of these data does not allow definitive conclusions because the available case reports and clinical trials are fragmented and incomplete.
Url:
DOI: 10.1592/phco.22.13.1157.33525
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000093
- to stream Istex, to step Curation: 000093
- to stream Istex, to step Checkpoint: 001073
- to stream Main, to step Merge: 002268
- to stream Main, to step Curation: 002246
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">A Review of Methotrexate‐Induced Accelerated Nodulosis</title>
<author><name sortKey="Patatanian, Edna" sort="Patatanian, Edna" uniqKey="Patatanian E" first="Edna" last="Patatanian">Edna Patatanian</name>
</author>
<author><name sortKey="Thompson, Dennis F" sort="Thompson, Dennis F" uniqKey="Thompson D" first="Dennis F." last="Thompson">Dennis F. Thompson</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:ED42B42E6B9566304EBE4EFE5202AE771AC54106</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1592/phco.22.13.1157.33525</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-R9Z6093G-M/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000093</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000093</idno>
<idno type="wicri:Area/Istex/Curation">000093</idno>
<idno type="wicri:Area/Istex/Checkpoint">001073</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001073</idno>
<idno type="wicri:doubleKey">0277-0008:2002:Patatanian E:a:review:of</idno>
<idno type="wicri:Area/Main/Merge">002268</idno>
<idno type="wicri:Area/Main/Curation">002246</idno>
<idno type="wicri:Area/Main/Exploration">002246</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">A Review of Methotrexate‐Induced Accelerated Nodulosis</title>
<author><name sortKey="Patatanian, Edna" sort="Patatanian, Edna" uniqKey="Patatanian E" first="Edna" last="Patatanian">Edna Patatanian</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Oklahoma</region>
</placeName>
<wicri:cityArea>Department of Pharmacy Practice, Southwestern Oklahoma State University, Weatherford</wicri:cityArea>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Thompson, Dennis F" sort="Thompson, Dennis F" uniqKey="Thompson D" first="Dennis F." last="Thompson">Dennis F. Thompson</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Oklahoma</region>
</placeName>
<wicri:cityArea>Department of Pharmacy Practice, Southwestern Oklahoma State University, Weatherford</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy</title>
<title level="j" type="alt">PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY</title>
<idno type="ISSN">0277-0008</idno>
<idno type="eISSN">1875-9114</idno>
<imprint><biblScope unit="vol">22</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="1157">1157</biblScope>
<biblScope unit="page" to="1162">1162</biblScope>
<biblScope unit="page-count">6</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2002-09">2002-09</date>
</imprint>
<idno type="ISSN">0277-0008</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0277-0008</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Adenosine</term>
<term>Antiinflammatory effects</term>
<term>Arthritis</term>
<term>Arthritis rheum</term>
<term>Case reports</term>
<term>Causality</term>
<term>Colchicine</term>
<term>Colchicine regression</term>
<term>Concurrent vasculitis</term>
<term>High percentage</term>
<term>Hydroxychloroquine</term>
<term>Methotrexate</term>
<term>Methotrexate therapy</term>
<term>Naranjo scale</term>
<term>Nodule</term>
<term>Nodulosis</term>
<term>Pharmacotherapy volume</term>
<term>Receptor</term>
<term>Rheum</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatoid factor</term>
<term>Rheumatoid nodules</term>
<term>Rheumatol</term>
<term>Vasculitis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Objective. To review the English‐language literature on methotrexate‐induced accelerated nodulosis, compile case reports of its occurrences, and make recommendations on the clinical management of patients. Methods. A comprehensive search of MEDLINE, TOXLINE, and EMBASE databases was performed, along with a bibliographic search of key articles. Case reports were compiled separately. The Naranjo adverse drug reaction probability scale was used to assess causality. Results. Twenty‐seven case reports of patients with methotrexate‐induced accelerated nodulosis were identified along with one series of 10 patients and one series of 21 patients. Probability assessment for most of the case reports was weak and left room for doubt regarding causality. Most patients were older than 50 years, were positive for rheumatoid factor, and had nodules on their fingers but did not have concurrent vasculitis. Some unusual sites of nodulosis were the larynx, lungs, Achilles tendon, and heart. Of 19 patients given hydroxychloroquine, colchicine, sulfasalazine, azathioprine, or D‐penicillamine, all except two showed regression of the nodules; the response was unknown for one patient. Conclusion. Controversy surrounds the management of patients who develop accelerated nodulosis while receiving methotrexate therapy for rheumatoid arthritis. Our review of these data does not allow definitive conclusions because the available case reports and clinical trials are fragmented and incomplete.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Oklahoma</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Oklahoma"><name sortKey="Patatanian, Edna" sort="Patatanian, Edna" uniqKey="Patatanian E" first="Edna" last="Patatanian">Edna Patatanian</name>
</region>
<name sortKey="Patatanian, Edna" sort="Patatanian, Edna" uniqKey="Patatanian E" first="Edna" last="Patatanian">Edna Patatanian</name>
<name sortKey="Thompson, Dennis F" sort="Thompson, Dennis F" uniqKey="Thompson D" first="Dennis F." last="Thompson">Dennis F. Thompson</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002246 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002246 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:ED42B42E6B9566304EBE4EFE5202AE771AC54106 |texte= A Review of Methotrexate‐Induced Accelerated Nodulosis }}
This area was generated with Dilib version V0.6.33. |